Philips Update: Respironics Issues Additional Usage Instructions for Trilogy Evo Ventilators Related to Use of In-Line Nebulizers Oct 07, 2024 | 3 minute read Additional Usage Instructions issued by Philips as voluntary correction (Urgent Medical Device Correction in the US, Field Safety Notice outside of the US)  Additional Usage Instructions provide user action and guidance for continued use of affected devices  Philips Respironics has not received any specific complaints of device malfunctions resulting from in-line nebulizer use; issue identified by retrospective review of flow sensor performance Philips Respironics   Philips Respironics issued a voluntary correction for Trilogy Evo, Trilogy Evo O2, Trilogy Evo Universal, and Trilogy EV300 ventilators regarding the use of in-line nebulizers.

飞利浦最新消息：Respironics发布了与使用在线雾化器有关的Trilogy Evo呼吸机的其他使用说明2024年10月7日| 3分钟阅读飞利浦发布的其他使用说明作为自愿更正（美国紧急医疗器械更正，美国境外的现场安全通知）其他使用说明为用户继续使用受影响的设备提供了操作和指导飞利浦Respironics没有收到任何关于在线雾化器使用导致的设备故障的具体投诉；通过对流量传感器性能的回顾性审查确定的问题飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸系统飞利浦呼吸。

An Urgent Medical Device Correction (Field Safety Notice in the rest of world) is being sent to health systems and equipment distributors and is being communicated through this additional update to ensure patients who use the devices at home are informed in a timely manner. Patients will receive communication from their usual health provider and should not discontinue therapy without consulting their healthcare provider.

正在向卫生系统和设备分销商发送紧急医疗设备更正（世界其他地区的现场安全通知），并通过此附加更新进行沟通，以确保及时告知在家使用设备的患者。患者将从他们通常的医疗保健提供者那里获得沟通，不应在未咨询其医疗保健提供者的情况下停止治疗。

This update, and the associated Urgent Medical Device Correction (Field Safety Notice in the rest of world) provides instructions for user action and guidance for continued use of affected devices.  Philips Respironics is investigating a solution and will provide additional information when available.  Philips Respironics has not received any specific complaints of device malfunctions resulting from in-line nebulizer use.

此更新以及相关的紧急医疗器械纠正（世界其他地区的现场安全通知）提供了用户操作说明和继续使用受影响设备的指导。飞利浦Respironics正在研究一种解决方案，并将在可用时提供更多信息。飞利浦Respironics没有收到任何关于在线雾化器使用导致设备故障的具体投诉。

As part of ongoing quality management, the company performed a retrospective review and identified a potential.

作为持续质量管理的一部分，该公司进行了回顾性审查，并确定了潜在的。